Fig. 3

Distribution and outcome of “CD27⁻IFN-γ⁺CD4⁺” in peripheral blood after normal anti-TB therapy. a Total percentage of “CD27⁻IFN-γ⁺CD4⁺” cells after treatment. b The percentage of “CD27⁻IFN-γ⁺CD4⁺” in < 30 years group. c The percentage of “CD27⁻IFN-γ⁺CD4⁺” in 30–50 years group. d The percentage of “CD27⁻IFN-γ⁺CD4⁺” in > 50 years group. Data are presented as the mean ± standard deviation of at least three independent experiments. ^*P < 0.05 vs. no therapy at 0 month. **P < 0.01 vs. no therapy at 0 month. ^***P < 0.0001 vs. no therapy at 0 month